Moors & Cabot, Inc. Teva Pharmaceutical Industries LTD Transaction History

Moors & Cabot, Inc.

$1.85 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.9 - $10.19 $83,977 - $108,319	-10,630 Closed	0 $0
Q3 2021 Dec 08, 2021	SELL	$8.38 - $10.18 $199,033 - $241,785	-23,751 Reduced 69.08%	10,630 $104,000
Q3 2021 Nov 05, 2021	BUY	$8.38 - $10.18 $183,656 - $223,104	21,916 Added 175.82%	34,381 $1.49 Million
Q2 2021 Aug 10, 2021	SELL	$9.9 - $11.56 $35,788 - $41,789	-3,615 Reduced 22.48%	12,465 $123,000
Q1 2021 May 12, 2021	SELL	$10.34 - $12.81 $139,434 - $172,742	-13,485 Reduced 45.61%	16,080 $188,000
Q4 2020 Feb 11, 2021	SELL	$8.61 - $11.04 $51,401 - $65,908	-5,970 Reduced 16.8%	29,565 $289,000
Q3 2020 Nov 09, 2020	SELL	$8.57 - $12.69 $61,489 - $91,050	-7,175 Reduced 16.8%	35,535 $320,000
Q2 2020 Aug 13, 2020	BUY	$8.12 - $13.12 $33,332 - $53,857	4,105 Added 10.63%	42,710 $524,000
Q1 2020 May 12, 2020	SELL	$6.69 - $13.45 $31,108 - $62,542	-4,650 Reduced 10.75%	38,605 $343,000
Q4 2019 Jan 28, 2020	BUY	$6.53 - $10.72 $136,300 - $223,758	20,873 Added 93.26%	43,255 $429,000
Q3 2019 Oct 22, 2019	BUY	$6.16 - $9.6 $27,381 - $42,672	4,445 Added 24.78%	22,382 $152,000
Q2 2019 Jul 18, 2019	SELL	$8.12 - $15.72 $15,939 - $30,858	-1,963 Reduced 9.86%	17,937 $165,000
Q1 2019 May 06, 2019	SELL	$15.58 - $20.01 $310,042 - $398,199	-19,900 Reduced 50.0%	19,900 $316,000
Q1 2019 May 01, 2019	BUY	$15.58 - $20.01 $188,518 - $242,121	12,100 Added 43.68%	39,800 $632,000
Q4 2018 Feb 13, 2019	SELL	$14.59 - $23.84 $307,878 - $503,071	-21,102 Reduced 43.24%	27,700 $434,000
Q3 2018 Nov 14, 2018	BUY	$21.06 - $25.65 $337,486 - $411,041	16,025 Added 48.89%	48,802 $1.06 Million
Q2 2018 Aug 14, 2018	BUY	$16.77 - $24.71 $266,139 - $392,147	15,870 Added 93.87%	32,777 $788,000
Q1 2018 May 18, 2018	BUY	$16.68 - $22.07 $27,605 - $36,525	1,655 Added 10.85%	16,907 $289,000
Q4 2017 Feb 13, 2018	SELL	$11.23 - $19.1 $82,574 - $140,442	-7,353 Reduced 32.53%	15,252 $294,000
Q3 2017 Nov 16, 2017	SELL	$15.41 - $32.17 $33,609 - $70,162	-2,181 Reduced 8.8%	22,605 $404,000
Q2 2017 Aug 15, 2017	BUY	N/A	24,786	24,786 $823,000

Others Institutions Holding TEVA

# of Institutions

617

Shares Held

563M

Call Options Held

25.2M

Put Options Held

5.08M

Black Rock Inc. New York, NY

43M
Shares

$752 Million
0.02% of portfolio
Ion Asset Management Ltd. George Town, Grand Cayman, E9

36.3M
Shares

$636 Million
41.14% of portfolio
Clal Insurance Enterprises Holdings LTD Tel Aviv, L3

32.3M
Shares

$566 Million
5.5% of portfolio
Menora Mivtachim Holdings Ltd.

28.8M
Shares

$505 Million
3.23% of portfolio
Exor Capital LLP London, X0

26.5M
Shares

$463 Million
15.49% of portfolio

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.

Account